Related Experiment Videos
Summary
High doses of griseofulvin, an antifungal medication, given to pregnant rats during development caused reduced survival and malformations in offspring. These findings highlight potential risks of griseofulvin teratogenicity.
Area of Science:
- Pharmacology
- Toxicology
- Developmental Biology
Background:
- Griseofulvin is an antifungal drug used to treat fungal infections.
- Understanding the safety profile of medications during pregnancy is crucial.
Purpose of the Study:
- To investigate the potential teratogenic effects of griseofulvin in pregnant rats.
- To evaluate the impact of high-dose griseofulvin exposure on offspring development.
Main Methods:
- Pregnant rats were administered oral doses of griseofulvin ranging from 125 to 1500 mg/kg/day during organogenesis.
- Offspring were evaluated for survival rates and malformations.
Main Results:
- Dams treated with high doses (63 and 75 times human therapeutic dose) exhibited decreased offspring survival.
- A significant syndrome of malformations was observed in the offspring exposed to the highest griseofulvin doses.
Conclusions:
- Griseofulvin, at doses significantly exceeding therapeutic levels, can induce adverse developmental outcomes in rats.
- These findings suggest a potential teratogenic risk associated with high griseofulvin exposure during pregnancy.